Sodium Nitroprusside Dihydrate
CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate( Sodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate )
Catalog No. M17986 CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 41 | In Stock |
|
| 1G | 42 | In Stock |
|
Biological Information
-
Product NameSodium Nitroprusside Dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
-
DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.(In Vitro):Nitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In VitroNitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In Vivo——
-
SynonymsSodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptorguanylate cyclase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number13755-38-9
-
Formula Weight297.95
-
Molecular FormulaC5H4FeN6Na2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 46 mg/mL; 154.39 mM
-
SMILES[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Befotertinib
Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.
-
Canertinib dihydroch...
A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay.
-
EGFR-IN-7
EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.
Cart
sales@molnova.com